Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1973 1
1994 1
1995 1
1997 1
1999 1
2001 2
2002 1
2005 1
2006 1
2007 1
2008 1
2009 2
2010 3
2011 2
2012 3
2015 1
2017 4
2018 9
2019 4
2020 4
2021 3
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer.
Shirasawa M, Fukui T, Kusuhara S, Harada S, Nishinarita N, Hiyoshi Y, Ishihara M, Kasajima M, Igawa S, Yokoba M, Mitsufuji H, Kubota M, Katagiri M, Sasaki J, Naoki K. Shirasawa M, et al. Among authors: mitsufuji h. PLoS One. 2019 Apr 19;14(4):e0214599. doi: 10.1371/journal.pone.0214599. eCollection 2019. PLoS One. 2019. PMID: 31002722 Free PMC article.
The Glasgow Prognostic Score Predicts Survival in Patients with Advanced Non-Small Cell Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations Who Are Treated with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors.
Akazawa Y, Igawa S, Yamada K, Yamamoto H, Yagami Y, Kaizuka N, Manaka H, Kasajima M, Nakahara Y, Sato T, Mitsufuji H, Yokoba M, Kubota M, Sasaki J, Naoki K. Akazawa Y, et al. Among authors: mitsufuji h. Oncology. 2023;101(11):685-694. doi: 10.1159/000530809. Epub 2023 Apr 25. Oncology. 2023. PMID: 37166346 Free PMC article.
A Prospective Observational Study of Osimertinib for Chemo-Naive Elderly Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer.
Igawa S, Kasajima M, Ono T, Ozawa T, Kakegawa M, Kusuhara S, Sato T, Nakahara Y, Fukui T, Yokoba M, Kubota M, Mitsufuji H, Sasaki J, Naoki K. Igawa S, et al. Among authors: mitsufuji h. Cancer Manag Res. 2021 Nov 20;13:8695-8705. doi: 10.2147/CMAR.S339891. eCollection 2021. Cancer Manag Res. 2021. PMID: 34849025 Free PMC article.
Effect of gefitinib on warfarin antithrombotic activity.
Arai S, Mitsufuji H, Nishii Y, Onoda S, Ryuge S, Wada M, Katono K, Iwasaki M, Takakura A, Otani S, Yamamoto M, Yanaihara T, Yokoba M, Kubota M, Katagiri M, Fukui T, Kobayashi H, Yanase N, Hataishi R, Masuda N. Arai S, et al. Among authors: mitsufuji h. Int J Clin Oncol. 2009 Aug;14(4):332-6. doi: 10.1007/s10147-008-0871-2. Epub 2009 Aug 25. Int J Clin Oncol. 2009. PMID: 19705244
45 results